Skip to main content
. 2011 Sep 13;26(3):340–347. doi: 10.3904/kjim.2011.26.3.340

Table 1.

Characteristics of individual studies included in the systematic review and meta-analysis

graphic file with name kjim-26-340-i001.jpg

E, experimental group; C, control group; PMO, postmenopausal osteoporosis; MOTION, the monthly oral therapy with ibandronate for osteoporosis intervention study; PERSIST, the persistence study of ibandronate versus alendronate; BALTO, the Bonviva alendronate trial in osteoporosis; MOBILE, the monthly oral ibandronate in ladies; BMD, bone mineral density; GI, gastrointestinal.